Skip to main content

Genome Canada Pumps $10M into Genomics, Proteomics Centers

NEW YORK (GenomeWeb News) – Genome Canada has awarded C$10 million ($9.7 million) in new funding to two Science and Technology Innovation Centers (STICs) pursuing genomics and proteomics in British Columbia.

Genome BC said today that the new funding, awarded under Genome Canada's 2010 Science and Technology Innovation Centres Operation Support Competition, will provide C$6.6 million to the Michael Smith Genome Sciences Centre (GSC) in Vancouver and C$3.4 million to the University of Victoria Genome BC Proteomics Centre.

The STICs provide access to high-throughput genomics and proteomics technologies including DNA sequencing, RNA expression, protein identification and quantitation, protocols development, data analysis, and bioinformatics. The centers also support researchers in planning and executing their research plans and work with them to fit technologies to their projects and optimize their research.

The GSC plans to use the funding to sustain its DNA sequencing, bioinformatics, and technology development programs. The emphasis on bioinformatics is important, Genome BC said, because of the need for robust and flexible informatics pipelines and analysis tools in the era of large-scale, ultra high-throughput sequencing.

The Uvic-Genome BC Proteomics Centre will provide expertise in quantitative and structural proteomics, and it will specialize in providing tools and services for proteomics analysis applications including protein identification and characterization, biomarker discovery and validation, relative and absolute quantitation, custom assay development, and metabolite profiling.

"Genomics produces a huge amount of information for analysis and without the support of technology platforms it would be impossible to maximize the research outputs into real-world applications. This is why we are so gratified that these two centres will be able to offer support for genomics researchers in BC and Canada," Genome BC President and CEO Alan Winter said in a statement.

"Our Innovation Centre has been involved in projects in every competition funded by Genome Canada since 2001. To date, we have supported 26 large-scale projects funded by Genome Canada and Genome BC, including eight projects in BC recently funded as part of the Large Scale Applied Research Program," added GSC Director Marco Marra.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.